Analyst firms · Piper Sandler · ORCL

Piper Sandler ORCL price target and rating history

Oracle Corporation (ORCL) · Technology

Piper Sandler rates Oracle Corporation (ORCL) Overweight with a $270 price target, as of its latest action on Jul 10, 2025. It has published 6 rating actions on ORCL since December 2021, including 3 upgrades and 2 downgrades. Across 10 firms with a ORCL price target in the last 12 months, the median target is $219.

Current rating
Overweight
Price target
$270
Median target, all firms
$219
Actions on ORCL
6

Piper Sandler price target on ORCL

$270$170$7020222023202420252026
Piper Sandler price target on ORCL, each point a stated target, December 2021 to July 2025.

Every Piper Sandler rating on ORCL

How other firms rate ORCL

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
StephensOverweight$213Nov 2, 2026
BMO Capital MarketsOutperform$195Sep 11, 2026
CLSAHold$145Jul 20, 2026
OppenheimerOutperform$235May 12, 2026
Arete ResearchBuy$255May 7, 2026
WedbushOutperform$225Apr 24, 2026
Cleveland ResearchNeutralApr 10, 2026
BofA SecuritiesBuy$200Mar 24, 2026
MeliusHoldFeb 9, 2026
DA DavidsonBuy$180Feb 9, 2026
Goldman SachsBuy$240Jan 12, 2026
Wells FargoOverweight$280Dec 3, 2025

Questions about Piper Sandler and ORCL

What is Piper Sandler's price target for ORCL?
Piper Sandler's latest stated price target for Oracle Corporation (ORCL) is $270, from its action on Jul 10, 2025.
What is Piper Sandler's rating on ORCL?
Piper Sandler rates ORCL Overweight, a bullish rating, as of Jul 10, 2025.
When did Piper Sandler last change its view on ORCL?
On Jul 10, 2025, Piper Sandler upgrades to Overweight from Neutral, price target $270.
How does Piper Sandler's ORCL target compare with other analysts?
Across 10 firms with a ORCL price target in the last 12 months, the median target is $219.

More ORCL rating histories

All Piper Sandler ratingsORCL news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.